Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation

This study identifies <i>Vanin-1 (VNN1)</i> as a potential biomarker for systemic inflammation and highlights the role of <i>Plasminogen Activator, Tissue Type (PLAT)</i> in vascular dysfunction, emphasizing the critical importance of glycemic control in mitigating molecular and clinical dysregulation. These findings underscore the need for personalized, sex-specific strategies to manage these comorbidities effectively.